Printer Friendly

ADME and Translational Pharmacokinetics/ Pharmacodynamics of Therapeutic proteins: Applications in Drug Discovery and Development.

9781118898642

ADME and Translational Pharmacokinetics/ Pharmacodynamics of Therapeutic proteins: Applications in Drug Discovery and Development

Edited by Honghui Zhou and Frank-Peter Theil

Wiley

2016

448 pages

$150.00

Hardcover

RM301

Pharmaceutical researchers from the US, Europe, and Asia offer 27 chapters on the ADME (absorption, distribution, metabolism, and excretion) and translational pharmacokinetics/pharmacodynamics of therapeutic proteins, particularly monoclonal proteins. They report on ADME research and small molecule drugs; the applications of protein engineering to therapeutic proteins and antibodies; protein engineering to influence ADME, pharmacokinetics, and efficacy; antibody-derived proteins and proteins with novel scaffolds; antibody-drug conjugates; the role of the lymphatic system in subcutaneous absorption of therapeutic proteins; biodistribution; the prediction of human pharmacokinetics for protein-based biologic therapeutics; fixed dosing vs. body-size-based dosing; the impact of diseases, comorbidity, and target physiology on ADME, pharmacokinetics, and pharmacodynamics; and immunogenicity. Others discuss mechanistic physiologically based pharmacokinetic models in the development of therapeutic monoclonal antibodies; integrated quantitation of biotherapeutic drug-target binding, biomarkers, and clinical response to support rational dose regimen selection; target-driven pharmacokinetics; tumor and brain effect site pharmacokinetics; molecular pathology techniques in the preclinical development of therapeutic biologics; labeling and imaging techniques for quantification; how knowledge of ADME of therapeutic proteins in adults facilitates pediatric development; liquid chromatography mass spectrometry vs. immune-based bioanalytical methods in quantitation; biosimilar development; vaccines; drug development strategies; clinical pharmacology in the development of biologics; a case study of the nonclinical ADME and pharmacokinetics/pharmacodynamics of an antibody-drug conjugate; and the use of pharmacokinetics/pharmacodynamics knowledge in guiding bispecific biologics research and development. ([umlaut] Ringgold, Inc., Portland, OR)

COPYRIGHT 2016 Ringgold, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:ProtoView
Article Type:Book review
Date:Jan 1, 2016
Words:259
Previous Article:Treating PTSD in Preschoolers: A Clinical Guide.
Next Article:Model-Based System Architecture.
Topics:

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |